mjc159/others: First and foremost: SORRY for mistyping in my previous post as the correct spelling of course is ACADIA !
mjc159: Thanks for your reply. Yes, indeed, ACADIA just might like Switzerland as a location - even though it is a very high-priced country within Europe and with a very small domestic market...
I was just trying to think a bit "outside the box" - but perhaps wrongly, naturally! However, I believe that NOVARTIS (more than enough cashed-up and with some interests in 'rare diseases') could be a company that could take-over both ACADIA as well as NEU - IF they would really be interested....
I am most curious to see where the ROW will go. And when. Moreover, I would NOT like to see ACADIA getting those. But this is just me, perhaps?
wasa
TROFINETIDE TRIALS UPDATE, page-219
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |